Completed
Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of Camlipixant
NCT05899829
- Conditions
- Cough, Healthy, Pathological Conditions, Signs and Symptoms, +4 more
- Locations
-
- GSK Investigational Site Québec, Quebec, Canada